
The Call for Abstracts for the SMDM 2027 Annual Meeting is now open! Join us in Toronto, 6–9 June 2027, and bring the work that’s moving medical decision making forward. #SMDM27 Submit at buff.ly/INUwuz0

@WCMPopHealthSci @CHERISHresearch | graduate of @UWMadEngr and @DuluthMarshall | avid reader, long walker, and par taker of civ 6 🌈

The Call for Abstracts for the SMDM 2027 Annual Meeting is now open! Join us in Toronto, 6–9 June 2027, and bring the work that’s moving medical decision making forward. #SMDM27 Submit at buff.ly/INUwuz0

Dan Fisher opened his press conference by addressing the NCAA's proposed December transfer portal window, which would fall right before the round of 16. Administrators vote early next week. Here's what he had to say:

Excited to see one of my favorites - Caroline Andy from @ali_jalali_ lab and div of biostatistics at @WCMPopHealthSci - present at @AHSRConference #ahsr2026

Our fall conference roundups are live! Connect with CHERISH colleagues and affiliated researchers as they make appearances at #AHSR2026, #INHSU2026, and #IDWeek2026 this month. View the schedules here: cherishresearch.org/news-and….

.@GutkindSarah speaks to packed room at @AHSRConference on state Medicaid waiver provisions for substance use services for youth

“It feels like we’re making things better here. I’d hate to see that go away.” read more here: minnpost.com/mental-health-a…

I was in notified by the same insurance company, Blue Cross and Blue Shield of Minnesota that the patient has to fail thalidomide first before receiving Len. So I am now in the year 2002 please RT this so executives at Blue Cross and Blue Shield. See what a bunch of morons they R

My patient with high risk multiple myeloma and cardiac amyloidosis received Dara CyBord had a short-lived response and relapsed. I attempted to begin the process for CAR-T and was notified by Blue Cross Blue Shield of Minnesota that the patient has to fail lenalidomide first.. 👇

We look forward to learning from Dr. Daniel Polsky at today’s Grand Rounds. Dr. Polsky joins us from @JHU_BDPs, @JohnsHopkinsSPH, and @JHUCarey: bit.ly/4cl9ly7

We're thrilled to have Dr. Daniel Polsky (@JHU_BDPs, @JohnsHopkinsSPH, @JHUCarey) present at our Grand Rounds next week: bit.ly/4cl9ly7

Opioid agonist treatment (OAT) can improve HIV outcomes for people with opioid use disorder. In @AIDS_Journal, @CzarinaBehrends and @BruceSchackman explain the urgent need to evaluate the true cost of providing OAT around the world: bit.ly/46gvFVf

Both high and increasing addictive screen use trajectories were associated with suicidal behaviors, suicidal ideation, and worse mental health in US youths. ja.ma/4meiZof @YunyuXiaoPhD

JCOIN is accepting applications for the Rapid Innovation Grant (J-RIG), offering up to $135K for short-term projects addressing addiction and overdose in criminal legal populations. Apply by August 31, 2025: jcoinctc.org/resources/j-rig…

We are pleased to announce the 2025-2026 CHERISH pilot grant recipients! Continue to our site to learn about their research identifying opportunities and challenges in delivering substance use and HCV/HIV care to rural and high-risk populations: cherishresearch.org/news-and…

JAMA Pediatrics is offering a 2-year editorial fellowship position for a qualified individual who will be supported with a small stipend. Read this Call for Applications to learn more. ja.ma/3G5nge6

A new study in @JAMAHealthForum from Dr. Angelica Meinhofer and colleagues finds that state school Medicaid expansions led to increased access to Medicaid-funded school-based health services for children who have experienced parental opioid use disorder: bit.ly/4dYJr1X